{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T14:41:00Z","timestamp":1772548860255,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,3]]},"DOI":"10.7759\/cureus.104600","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T10:43:20Z","timestamp":1772534600000},"source":"Crossref","is-referenced-by-count":0,"title":["Simultaneous Bilateral Central Retinal Artery Occlusions: Partial Recovery With Multimodal Therapy"],"prefix":"10.7759","author":[{"given":"Jessie R","family":"Cai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glen  C","family":"Hawkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Newton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian C","family":"Francis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.oret.2023.12.007","article-title":"Central retinal artery occlusion: visual outcomes from a large northern California cohort","volume":"8","author":"Shah R","year":"2024","unstructured":"Shah R, Zheng X, Patel AP, Bhatti MT, Gilbert A, Vora RA. Central retinal artery occlusion: visual outcomes from a large northern California cohort. Ophthalmol Retina. 2024, 8:566-70. 10.1016\/j.oret.2023.12.007","journal-title":"Ophthalmol Retina"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1161\/STR.0000000000000366","article-title":"Management of central retinal artery occlusion: a scientific statement from the American Heart Association","volume":"52","author":"Grory BM","year":"2021","unstructured":"Grory BM, Schrag M, Biousse V, et al.. Management of central retinal artery occlusion: a scientific statement from the American Heart Association. Stroke. 2021, 52:e282-94. 10.1161\/STR.0000000000000366","journal-title":"Stroke"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2011.05.005","article-title":"The incidence of central retinal artery occlusion in Olmsted County, Minnesota","volume":"152","author":"Leavitt JA","year":"2011","unstructured":"Leavitt JA, Larson TA, Hodge DO, Gullerud RE. The incidence of central retinal artery occlusion in Olmsted County, Minnesota. Am J Ophthalmol. 2011, 152:820-3.e2. 10.1016\/j.ajo.2011.05.005","journal-title":"Am J Ophthalmol"},{"key":"ref4","article-title":"Central retinal artery occlusion","author":"Tripathy K","year":"2025","unstructured":"Tripathy K, Shah SS, Waymack JR. Central retinal artery occlusion. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2025."},{"key":"ref5","doi-asserted-by":"crossref","DOI":"10.1016\/S1474-4422(25)00308-4","article-title":"Intravenous alteplase versus oral aspirin for acute central retinal artery occlusion within 4.5 h of severe vision loss (THEIA): a multicentre, double-dummy, patient-blinded and assessor-blinded, randomised, controlled, phase 3 trial","volume":"24","author":"Pr\u00e9terre C","year":"2025","unstructured":"Pr\u00e9terre C, Gaultier A, Obadia M, et al.. Intravenous alteplase versus oral aspirin for acute central retinal artery occlusion within 4.5 h of severe vision loss (THEIA): a multicentre, double-dummy, patient-blinded and assessor-blinded, randomised, controlled, phase 3 trial. Lancet Neurology. 2025, 24:909-919.","journal-title":"Lancet Neurology"},{"key":"ref6","doi-asserted-by":"crossref","DOI":"10.1001\/archopht.120.9.1234","article-title":"Screening for retinopathy of prematurity using wide-field digital retinal imaging: sensitivity and specificity","volume":"120","author":"Fielder AR","year":"2002","unstructured":"Fielder AR, Cocker KD, Capone A Jr, Trese MT. Screening for retinopathy of prematurity using wide-field digital retinal imaging: sensitivity and specificity. Arch Ophthalmol. 2002, 120:1234.","journal-title":"Arch Ophthalmol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1177\/1747493016687578","article-title":"Management of acute central retinal artery occlusion: intravenous thrombolysis is feasible and safe","volume":"12","author":"Pr\u00e9terre C","year":"2017","unstructured":"Pr\u00e9terre C, Godeneche G, Vandamme X, et al.. Management of acute central retinal artery occlusion: intravenous thrombolysis is feasible and safe. Int J Stroke. 2017, 12:720-3. 10.1177\/1747493016687578","journal-title":"Int J Stroke"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1177\/23969873251344199","article-title":"Tenecteplase in central retinal artery occlusion study (TenCRAOS): protocol for a randomized-controlled trial","volume":"10","author":"Ryan SJ","year":"2025","unstructured":"Ryan SJ, J\u00f8rstad \u00d8K, Skjelland M, et al.. Tenecteplase in central retinal artery occlusion study (TenCRAOS): protocol for a randomized-controlled trial. Eur Stroke J. 2025, 10:1502-10. 10.1177\/23969873251344199","journal-title":"Eur Stroke J"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1177\/17474930241248516","article-title":"Early REperfusion therapy with intravenous alteplase for recovery of VISION in acute central retinal artery occlusion (REVISION): Study protocol of a phase III trial","volume":"19","author":"Poli S","year":"2024","unstructured":"Poli S, Grohmann C, Wenzel DA, et al.. Early REperfusion therapy with intravenous alteplase for recovery of VISION in acute central retinal artery occlusion (REVISION): Study protocol of a phase III trial. Int J Stroke. 2024, 19:823-9. 10.1177\/17474930241248516","journal-title":"Int J Stroke"},{"key":"ref10","doi-asserted-by":"crossref","DOI":"10.1016\/S0014-4835(03)00214-8","article-title":"Central retinal artery occlusion.: retinal survival time","volume":"78","author":"Hayreh SS","year":"2004","unstructured":"Hayreh SS, Zimmerman MB, Kimura A, Sanon A. Central retinal artery occlusion.: retinal survival time. Exp Eye Res. 2004, 78:723-736.","journal-title":"Exp Eye Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.111.613653","article-title":"Efficacy of intravenous tissue-type plasminogen activator in central retinal artery occlusion: report from a randomized, controlled trial","volume":"42","author":"Chen CS","year":"2011","unstructured":"Chen CS, Lee AW, Campbell B, et al.. Efficacy of intravenous tissue-type plasminogen activator in central retinal artery occlusion: report from a randomized, controlled trial. Stroke. 2011, 42:2229-34. 10.1161\/STROKEAHA.111.613653","journal-title":"Stroke"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000209862","article-title":"Thrombolysis after dabigatran reversal for acute ischemic stroke: a national registry-based study and meta-analysis","volume":"103","author":"Theodorou A","year":"2024","unstructured":"Theodorou A, Melanis K, Bakola E, et al.. Thrombolysis after dabigatran reversal for acute ischemic stroke: a national registry-based study and meta-analysis. Neurology. 2024, 103:e209862. 10.1212\/WNL.0000000000209862","journal-title":"Neurology"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2017.08.018","article-title":"Two-year follow-up of patients treated with dabigatran for stroke prevention in atrial fibrillation: Global Registry on Long-Term Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) registry","volume":"198","author":"Huisman MV","year":"2018","unstructured":"Huisman MV, Rothman KJ, Paquette M, et al.. Two-year follow-up of patients treated with dabigatran for stroke prevention in atrial fibrillation: Global Registry on Long-Term Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) registry. Am Heart J. 2018, 198:55-63. 10.1016\/j.ahj.2017.08.018","journal-title":"Am Heart J"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2023.152183","article-title":"Impact of previous glucocorticoid therapy on diagnostic accuracy of [18F] FDG PET-CT in giant cell arteritis","volume":"60","author":"Narv\u00e1ez J","year":"2023","unstructured":"Narv\u00e1ez J, Estrada P, Vidal-Montal P, S\u00e1nchez-Rodr\u00edguez I, Sabat\u00e9-Llobera A, Nolla JM, Cort\u00e9s-Romera M. Impact of previous glucocorticoid therapy on diagnostic accuracy of [18F] FDG PET-CT in giant cell arteritis. Semin Arthritis Rheum. 2023, 60:152183. 10.1016\/j.semarthrit.2023.152183","journal-title":"Semin Arthritis Rheum"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.86.5.530","article-title":"Effect of prior steroid treatment on temporal artery biopsy findings in giant cell arteritis","volume":"86","author":"Ray-Chaudhuri N","year":"2002","unstructured":"Ray-Chaudhuri N, Ah Kin\u00e9 D, Tijani SO, Parums DV, Cartlidge N, Strong NP, Dayan MR. Effect of prior steroid treatment on temporal artery biopsy findings in giant cell arteritis. Br J Ophthalmol. 2002, 86:530-2. 10.1136\/bjo.86.5.530","journal-title":"Br J Ophthalmol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-223480","article-title":"2022 American College of Rheumatology\/EULAR classification criteria for giant cell arteritis","volume":"81","author":"Ponte C","year":"2022","unstructured":"Ponte C, Grayson PC, Robson JC, et al.. 2022 American College of Rheumatology\/EULAR classification criteria for giant cell arteritis. Ann Rheum Dis. 2022, 81:1647-53. 10.1136\/ard-2022-223480","journal-title":"Ann Rheum Dis"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S224192","article-title":"Hyperbaric oxygen therapy for central retinal artery occlusion: patient selection and perspectives","volume":"15","author":"Celebi AR","year":"2021","unstructured":"Celebi AR. Hyperbaric oxygen therapy for central retinal artery occlusion: patient selection and perspectives. Clin Ophthalmol. 2021, 15:3443-57. 10.2147\/OPTH.S224192","journal-title":"Clin Ophthalmol"},{"key":"ref18","article-title":"Hyperbaric treatment of central retinal artery occlusion","author":"Hendriksen S","year":"2025","unstructured":"Hendriksen S, Cooper JS. Hyperbaric treatment of central retinal artery occlusion. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2025."},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1177\/112067211002000603","article-title":"Ocular neovascularization following central retinal artery occlusion: prevalence and timing of onset","volume":"20","author":"Rudkin AK","year":"2010","unstructured":"Rudkin AK, Lee AW, Chen CS. Ocular neovascularization following central retinal artery occlusion: prevalence and timing of onset. Eur J Ophthalmol. 2010, 20:1042-6. 10.1177\/112067211002000603","journal-title":"Eur J Ophthalmol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0334907","article-title":"Chronic central retinal artery occlusion: clinical manifestations, ocular neovascular complications, and risk of stroke","volume":"20","author":"Song JR","year":"2025","unstructured":"Song JR, Woo SJ. Chronic central retinal artery occlusion: clinical manifestations, ocular neovascular complications, and risk of stroke. PLoS One. 2025, 20:e0334907. 10.1371\/journal.pone.0334907","journal-title":"PLoS One"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/465151-simultaneous-bilateral-central-retinal-artery-occlusions-partial-recovery-with-multimodal-therapy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T10:43:21Z","timestamp":1772534601000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/465151-simultaneous-bilateral-central-retinal-artery-occlusions-partial-recovery-with-multimodal-therapy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,3]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.104600","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,3]]}}}